Search Results - Darren R. Feldman
- Showing 1 - 20 results of 64
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
Treatment of CD30-Expressing Germ Cell Tumors and Sex Cord Stromal Tumors with Brentuximab Vedotin: Identification and Report of Seven Cases by Costantine Albany, Lawrence H. Einhorn, Lawrence Garbo, Thomas E. Boyd, Neil C. Josephson, Darren R. Feldman
Published 2017Artigo -
7
-
8
-
9
High Incidence of Thromboembolic Events in Patients Treated With Cisplatin-Based Chemotherapy: A Large Retrospective Analysis by Russell Moore, Nelly G. Adel, Elyn Riedel, Manisha Bhutani, Darren R. Feldman, Nour Elise Tabbara, Gerald A. Soff, Rekha Parameswaran, Hani Hassoun
Published 2011Artigo -
10
Progression‐free and overall survival in patients with relapsed/refractory germ cell tumors treated with single‐agent chemotherapy: Endpoints for clinical trial design by Darren R. Feldman, Sujata Patil, M. J. Trinos, Maryann Carousso, Michelle S. Ginsberg, Joel Sheinfeld, Dean F. Bajorin, George J. Bosl, Robert J. Motzer
Published 2011Artigo -
11
First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX–Targeting Peptide, [<sup>68</sup>Ga]Ga-DPI-4452, in Patients with Clear Cell Renal Cell Carcinoma by Michael S. Hofman, Ben Tran, Darren R. Feldman, Anna Pokorska-Bocci, Solen Pichereau, Jonathan Wessen, Mohammad B. Haskali, Richard Sparks, Olena Vlasyuk, Ivana Galetić
Published 2024Artigo -
12
Reduced Proficiency in Homologous Recombination Underlies the High Sensitivity of Embryonal Carcinoma Testicular Germ Cell Tumors to Cisplatin and Poly (ADP-Ribose) Polymerase Inhi... by Francesca Cavallo, Grazia Graziani, Cristina Antinozzi, Darren R. Feldman, Jane Houldsworth, George J. Bosl, R. S. K. Chaganti, Mary Ellen Moynahan, Maria Jasin, Marco Barchi
Published 2012Artigo -
13
Identification and Validation of a Gene Expression Signature That Predicts Outcome in Adult Men With Germ Cell Tumors by James E. Korkola, Jane Houldsworth, Darren R. Feldman, Adam B. Olshen, Li-Xuan Qin, Sujata Patil, Victor E. Reuter, George J. Bosl, R. S. K. Chaganti
Published 2009Artigo -
14
Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell Tumors by Samuel A. Funt, Sujata Patil, Darren R. Feldman, Robert J. Motzer, Dean F. Bajorin, Joel Sheinfeld, Satish K. Tickoo, Victor E. Reuter, George J. Bosl
Published 2019Artigo -
15
Development of a risk stratification system to guide treatment for female germ cell tumors by Jane Meisel, Kaitlin M. Woo, Nora Sudarsan, Jana Eng, Sujata Patil, Erin Jacobsen, Rajmohan Murali, Ginger J. Gardner, George J. Bosl, Carol Aghajanian, Darren R. Feldman
Published 2015Artigo -
16
Phase I Trial of Bevacizumab Plus Escalated Doses of Sunitinib in Patients With Metastatic Renal Cell Carcinoma by Darren R. Feldman, Michael Baum, Michelle S. Ginsberg, Hani Hassoun, Carlos D. Flombaum, Susanne Velasco, Patricia Fischer, Ellen A. Ronnen, Nicole Ishill, Sujata Patil, Robert J. Motzer
Published 2009Artigo -
17
TI-CE High-Dose Chemotherapy for Patients With Previously Treated Germ Cell Tumors: Results and Prognostic Factor Analysis by Darren R. Feldman, Joel Sheinfeld, Dean F. Bajorin, Patricia Fischer, Stefan Turkula, Nicole Ishill, Sujata Patil, Manjit S. Bains, Lilian Reich, George J. Bosl, Robert J. Motzer
Published 2010Artigo -
18
-
19
-
20
Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma by Ana M. Molina, Darren R. Feldman, Michelle S. Ginsberg, Glenn S. Kroog, Satish K. Tickoo, Xiaoyu Jia, Murielle Georges, Sujata Patil, Michael Baum, Victor E. Reuter, Robert J. Motzer
Published 2010Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Oncology
Cancer
Chemotherapy
Biology
Renal cell carcinoma
Germ cell tumors
Genetics
Gene
Surgery
Cisplatin
Cancer research
Gastroenterology
Pathology
Testicular cancer
Urology
Adverse effect
Confidence interval
Sunitinib
Clear cell renal cell carcinoma
Clinical endpoint
Clinical trial
Disease
Progression-free survival
Biochemistry
Environmental health
Etoposide
Hazard ratio
Kidney cancer